RGFields for Oncology
Aggressive Cancers (e.g., Glioblastoma)
Key Facts
About Anapole Technologies
Anapole Technologies is a private, pre-revenue medical device and drug delivery company commercializing a novel, non-invasive therapeutic platform based on Resonance Generating Fields (RGFields). The technology has shown clinical effectiveness against HIV and pre-clinical success in tuberculosis and certain cancers, positioning it as a potential paradigm shift in treatment modalities. Led by an experienced team with strong financial and military backgrounds, the company is seeking strategic partners to bring its cost-effective, scalable system to market. Its value proposition centers on high ROI for providers and broader patient access due to lower treatment costs and backward-compatible hardware upgrades.
View full company profile